Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNA3 | P22001 | 1/20 | 0.59 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.53 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.53 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.53 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.53 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.53 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.53 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.53 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.53 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.53 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.53 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.53 |
| ▸ | LTA4H | P09960 | 2/20 | 0.49 |
| ▸ | DRD2 | P14416 | 2/20 | 0.49 |
| ▸ | DRD4 | P21917 | 2/20 | 0.49 |
| ▸ | DRD3 | P35462 | 2/20 | 0.49 |
| ▸ | HTR1B | P28222 | 2/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.44 |
| ▸ | HTR1D | P28221 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2818268 | 0.92 | KCNA3 (0.58) | KCNA3HDAC3HDAC4HDAC1HDAC7 | |
| Ammonia Solution, Strong SCHEMBL22654341 | 0.91 | KCNA3 (0.56) | KCNA3HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL28980695 | 0.86 | KCNA3 (0.50) | KCNA3HDAC3HDAC4HDAC1HDAC7 | |
| Boric Acid SCHEMBL28980657 | 0.86 | KCNA3 (0.50) | KCNA3HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL12974250 | 0.83 | PPARA (0.61) | LTA4HL3MBTL1ALDH1A1 | |
| SCHEMBL17476362 | 0.82 | KCNA3 (0.55) | KCNA3HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL17476379 | 0.82 | KCNA3 (0.55) | KCNA3HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL17476369 | 0.82 | KCNA3 (0.55) | KCNA3HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL17476373 | 0.82 | KCNA3 (0.55) | KCNA3HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL17476360 | 0.82 | KCNA3 (0.55) | KCNA3HDAC3HDAC4HDAC1HDAC7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1979363-B1 | NOVEL SILANE COMPOUNDS AND USE THEREOF IN ORDER TO FUNCTIONALISE SOLID MEDIA AND IMMOBILISE BIOLOGICAL MOLECULES ON SAID MEDIA | COMMISSARIAT ENERGIE ATOMIQUE (FR) | 2011-05-25 | — | — | EP | claimed |
| US-20090029875-A1 | Novel Silane Compounds and Use of Same for Functionalizing Solid Supports and Immobilizing Biological Molecules on These Supports | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2009-01-29 | — | — | US | claimed |
| EP-1979363-A1 | NOVEL SILANE COMPOUNDS AND USE THEREOF IN ORDER TO FUNCTIONALISE SOLID MEDIA AND IMMOBILISE BIOLOGICAL MOLECULES ON SAID MEDIA | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2008-10-15 | — | — | EP | claimed |
| WO-2007088187-A1 | NOVEL SILANE COMPOUNDS AND USE THEREOF IN ORDER TO FUNCTIONALISE SOLID MEDIA AND IMMOBILISE BIOLOGICAL MOLECULES ON SAID MEDIA | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2007-08-09 | — | — | WO | claimed |
| US-20060188907-A1 | Patterning method, substrate for biomolecule immobilization using the patterning method, and biochip employing the substrate | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2006-08-24 | — | — | US | claimed |
| US-9657042-B2 | Silane compounds and use of same for functionalizing solid supports and immobilizing biological molecules on these supports | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2017-05-23 | — | — | US | disclosed |
| EP-1979363-B1 | NOVEL SILANE COMPOUNDS AND USE THEREOF IN ORDER TO FUNCTIONALISE SOLID MEDIA AND IMMOBILISE BIOLOGICAL MOLECULES ON SAID MEDIA | COMMISSARIAT ENERGIE ATOMIQUE (FR) | 2011-05-25 | — | — | EP | disclosed |
| US-20090297868-A1 | Method for Forming Self-Assembled Monolayer Film, and Structural Body and Field-Effect Transistor Having Same | TOPPAN PRINTING CO., LTD. (JP) | 2009-12-03 | — | — | US | disclosed |
| US-20090029875-A1 | Novel Silane Compounds and Use of Same for Functionalizing Solid Supports and Immobilizing Biological Molecules on These Supports | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2009-01-29 | — | — | US | disclosed |
| EP-1979363-A1 | NOVEL SILANE COMPOUNDS AND USE THEREOF IN ORDER TO FUNCTIONALISE SOLID MEDIA AND IMMOBILISE BIOLOGICAL MOLECULES ON SAID MEDIA | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2008-10-15 | — | — | EP | disclosed |
| WO-2007088187-A1 | NOVEL SILANE COMPOUNDS AND USE THEREOF IN ORDER TO FUNCTIONALISE SOLID MEDIA AND IMMOBILISE BIOLOGICAL MOLECULES ON SAID MEDIA | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2007-08-09 | — | — | WO | disclosed |
| US-20060188907-A1 | Patterning method, substrate for biomolecule immobilization using the patterning method, and biochip employing the substrate | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2006-08-24 | — | — | US | disclosed |
| EP-1683571-A1 | Patterning method, substrate for biomolecule immobilization using the patterning method, and biochip employing the substrate | Samsung Electronics Co., Ltd. (KR) | 2006-07-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090029875-A1 | Novel Silane Compounds and Use of Same for Functionalizing Solid Supports and Immobilizing Biological Molecules on These Supports | SELE, ILK, ZYX | KCNA3 3496/4885HDAC3 1160/4885HDAC4 260/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.